Journal Information

Statistics

Follow this link to access the full text of the article

Scientific Letter
Osimertinib for the Treatment of EGFR Mutation-Positive Lung Adenocarcinoma Complicated With Dermatomyositis
El osimertinib como tratamiento del adenocarcinoma de pulmón con mutación positiva del EGFR complicado con dermatomiositis
Masahiro Yamasakia,
Corresponding author
myamasanjp@yahoo.co.jp

Corresponding author.
, Naoko Matsumotoa, Shota Nakanob, Kazuma Kawamotoa, Masaya Taniwakia, Yusuke Izumia, Masaya Otoharaa, Shinji Nabeshimac, Nobuyuki Ohashid, Noboru Hattoric
a Department of Respiratory Disease, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Naka-ku, Hiroshima, Japan
b Department of Rheumatology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Naka-ku, Hiroshima, Japan
c Department of Molecular and Internal Medicine, Institute of Biomedical & Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan
d Ohashi Clinic, Naka-ku, Hiroshima, Japan
Read
1415
Times
was read the article
607
Total PDF
808
Total HTML
Share statistics
Article information
ISSN: 15792129
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 35 27 62
2024 October 34 15 49
2024 September 35 14 49
2024 August 58 32 90
2024 July 45 20 65
2024 June 42 23 65
2024 May 65 30 95
2024 April 32 25 57
2024 March 37 24 61
2024 February 44 24 68
2023 March 10 4 14
2023 February 30 17 47
2023 January 27 25 52
2022 December 36 30 66
2022 November 41 21 62
2022 October 40 31 71
2022 September 19 21 40
2022 August 29 45 74
2022 July 28 38 66
2022 June 24 29 53
2022 May 24 26 50
2022 April 29 36 65
2022 March 26 33 59
2022 February 15 17 32
2021 March 2 0 2
2020 December 1 0 1
Show all

Follow this link to access the full text of the article

Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?